Why DraftKings Chose to Double Down on Microbetting

 

Key Points:

  • Microbetting creates increased fan engagement and investment across every pitch, snap, or free throw.
  • While this is still in the early stages of adoption amongst bettors, the appetite and opportunity for growth exists amongst fans.
  • DraftKings signed a multi-year agreement with SimpleBet to use their technology to enable microbetting.

Commentary:

As sports betting has swept across the American landscape both fans and betting providers have sought out new and exciting options for wagering on games.

There is, of course, the traditional method of simply betting on the outcomes of games, but providers have increasingly looked at ways of encouraging bets that come with a more immediate payoff and sense of gratification for bettors.

The idea of betting on individual moments within a game rather than the outcome or point spread is called microbetting. SimpleBet, a B2B product development company that employs machine learning and real-time technology to make every moment of every sporting event a betting opportunity, has pioneered the technology that makes this kind of action possible.

The ability to create increased fan engagement and investment across every pitch, snap, or free throw is precisely the sort of thing that attracted DraftKings to sign a multi-year agreement with SimpleBet to incorporate their technology into the sports gaming giant’s platform.

Chris Bevilacqua, the CEO of SimpleBet, joined MarketScale to discuss the partnership with DraftKings and what makes microbetting so appealing to sports fans in 2021.

Abridged Thoughts:

Over the last call it, 18 months. But I think what has since happened, largely due to COVID, I believe, is that you’ve seen a real acceleration on the regulatory front. More states legalizing sports betting a lot faster than most thought and then everything sort of coming back to, I would say not all the way normal, but pretty close to normal, with fans now getting back in stadiums and seasonality and sport calendars getting back on track.

So you have all those things coming together at one time, and I think you’ve got just a general forward thrust here, right? With the things getting back to normal and this new sports betting interactivity, all the technology enabling features around product innovation and so forth have all kind of come together and what we’re seeing now and we now have been live on DraftKings for seven weeks, I believe, right?

More Stories Related To Microbetting:

How Sports Betting Took the U.S. by Storm

The Road to Becoming a Maverick of Sponsorships

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More